Opinion: Sickle cell cures are coming. African children can’t be left behind
Pharmaceutical companies, governments, and the global health care community must start working now to bridge the access gap.
The treatment of sickle cell disease is on the cusp of a historic breakthrough, with makers of two gene-based treatments for the debilitating blood disorder hoping for regulatory approval this year.
But for those with sickle cell in sub-Saharan Africa, where more than 60% of the 120 million people worldwide live with this disease, there is little cause to celebrate. A potential cure that could save them from severe illness and early death will exist — but its expected multimillion-dollar price tag will be far out of reach.
What's Your Reaction?
